Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
WISDOMTREE EURO STOXX 50® 3X DAILY SHORT SECURITIES ISIN: XS3306517502 PROPOSED AMENDMENT TO THE PRINCIPAL AMOUNT OF THE AFFECTED SECURITIES ADJOURNMENT OF MEETING OF THE ETP SECURITYHOLDERS
-
Revolut and Yuno Partner to Give Merchants One-Click Access to Revolut’s Full Payment Stack
-
3 E Network CEO Continues to Increase His Stake, Reflecting Confidence in the Company’s AI Strategy and Operational Results
-
AGM Group Holdings Inc.’s Full-Stack AI Storage Solutions Gain Traction, Expecting Significant Delivery Growth in H2 2026
-
Emergent BioSolutions Completes Repurchase of $75 Million Aggregate Principal Amount of Senior Unsecured Notes
-
C&B EUREKA INNOVATIONS CO., LIMITED：25 μΩ / ±0.1% / ±15 ppm/°C High-Precision Shunt Module Launched — ±0.3% Accuracy Across the Full Temperature Range Without Temperature Compensation
-
Javier Loya Says Hispanic Voters Are Setting the Terms as Proyecto Lone Star Launches in Texas
-
CoinShares XBT Provider AB (publ) - 2017 Issuance Programme Change of FX Source/FX Rate
-
CoinShares XBT Provider AB (publ) - 2015 Issuance Programme Change of FX Source/FX Rate
-
Hillman Completes Acquisition of Kanebridge
-
Volatus Aerospace Selected for Canada’s Defence Drone Initiative Marketplace
-
Electra to Showcase Growing North American Critical Minerals Platform at September Investor and Industry Conferences
-
FDA Grants Fast Track Designation to YUTREPIA® for the Treatment of Raynaud's Phenomenon Associated with Systemic Sclerosis
-
TG Therapeutics to Participate in the Cantor Global Healthcare Conference
-
Trevi Therapeutics to Participate in Upcoming September Conferences
-
ESGold Commences Diamond Drilling at Its Montauban Project, Québec
-
Helus Pharma to Participate at the 2026 Cantor Global Healthcare Conference in New York
-
Eikon Therapeutics Appoints Ching-Pin Chang, M.D., Ph.D. as Executive Vice President and Chief Scientific Officer
-
FDA Grants Fast Track Designation to YUTREPIA® for the Treatment of Raynaud's Phenomenon Associated with Systemic Sclerosis
-
Morocco Strategic Minerals Corp. Completes Sale of Initial 51% Interest in Sakami Property in Québec
-
Kobo Resources Extends Gold Mineralisation to the North at Kossou with Multiple High-Grade Drill Intercepts
-
Rekor Eliminates Approximately $10 Million in Liabilities and Generates More Than $2 Million in Annual Savings
-
Saia Provides July and August LTL Operating Data
-
Dyne Therapeutics to Present Preclinical Data for Multiple Development Candidates for Duchenne Muscular Dystrophy (DMD) at 27th Annual NMSG Scientific Meeting
-
Structure Therapeutics to Participate in Upcoming Healthcare Investor Conferences
-
Crescent Biopharma to Present at September Investor Conferences
-
MiniLuxe Announces New Mansfield Studio Opening Through Joint Venture with Entrepreneur Vera Vos-Lexmond
-
Wood Mackenzie: Natural Carbon Sinks Absorb 40% of Human CO2 Emissions and Are Not Valued in Most Climate Models
-
Amwell® receives Frost & Sullivan's 2026 Technology Innovation Leadership Recognition for addressing healthcare fragmentation
-
Kraig Biocraft Laboratories Highlighted by Tech Times for Advancing Spider Silk from Science Fiction Toward Commercial Reality
-
Amwell® receives Frost & Sullivan's 2026 Technology Innovation Leadership Recognition for addressing healthcare fragmentation
-
Alterity Therapeutics to Participate in a Fireside Chat at the Cantor Global Healthcare Conference 2026
-
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
EdgeMode secures FINRA completion of Form 211 review, permitting sponsoring market maker to initiate quotations
-
Stallion Completes Ground Gravity, Identifies Three New Priority Target Areas At Stone Island
-
Rubicon Organics Announces Details of Annual General Meeting
-
Real Matters Announces Departure of Chief Financial Officer
-
CANADA’S FAVOURITE COOKIE BRAND CELEBRATES 25TH STORE OPENING IN PORT CREDIT MISSISSAUGA AS NATIONAL FRANCHISE EXPANSION ACCELERATES
-
BlossomHill Therapeutics to Present at the 8th Annual RAS-Targeted Drug Development Summit & H.C. Wainwright 28th Annual Global Investment Conference
-
GXO Expands Technology Organization To Enable Scale and Resilience and Accelerate Innovation
-
Newron Pharmaceuticals to Participate in H.C. Wainwright 28th Annual Global Investment Conference
-
Cartesian Therapeutics to Participate in Upcoming Investor Conferences
-
Victoria’s Secret & Co. Reports Second Quarter 2026 Results
-
Aurora Mobile Showcases AI Solutions for Customer Engagement at Tokyo’s AI Expo Summer 2026
-
Alternative Ballistics Appoints Sertan Ayçiçek to Help Drive Global Expansion, Strategic Investment and Commercial Growth
-
Eledon Pharmaceuticals Announces Islet Cell Transplantation IND Submission, First Patients Enrolled in Multiple Transplant Programs, and Reaffirms Plan to Initiate Phase 3 Kidney Transplantation Trial
-
Fate Therapeutics to Participate in Fireside Chat at the 2026 Annual Cantor Global Healthcare Conference
-
Gyre Therapeutics to Participate in Upcoming September Investor Conferences
-
C4 Therapeutics to Present New Biomarker Data on the Immunomodulatory Effects of Cemsidomide in Combination with Dexamethasone from its Phase 1 Relapsed/Refractory Multiple Myeloma Trial at the 23rd I
-
LeonaBio to Participate in Cantor Global Healthcare Conference 2026
